Investment Opportunities in the Medical Device Sector

At this stop on Pharma's Almanac's Road to 50 States trans-American trip, Jarrett Beachem, Vice President of Business Development at Madison Street Capital, talks to Nigel about the medical device industry and what trends he sees in the investment space going forward.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Madison Street Capital

Madison Street Capital is an international investment banking firm committed to integrity, excellence, leadership and service in delivering corporate financial advisory services to publicly and privately held businesses.

The methodology we apply reflects substantial expertise and experience in all areas of corporate finance, including mergers and acquisitions, due diligence and market pricing, specialized financings, valuation, deal structuring, and the design and implementation of alternative exit strategies.

Madison Street Capital understands the time sensitivity of corporate finance and is able to respond quickly and tenaciously to opportunities. Our approach creates corporate finance transactions where both business owners and investors mutually benefit. We have the knowledge, experience and relationships to match buyers and sellers, as well as to match the appropriate financing and capitalization structure to each unique client situation.

Over the years we have helped clients in hundreds of industry verticals reach their goal in a timely manner. Our experience and understanding in areas of corporate finance and corporate governance is the reason we are a leading provider of financial advisory services, M&A, and valuations. With offices in North America, Asia and Africa, we have adopted a global view that gives equal emphasis to local business relationships and networks.

Q: